Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model

Studies have reported conflicting results on the association between the use of renin-angiotensin-aldosterone system (RAAS) inhibitors and cancer development. We compared the incidence of cancer between patients using RAAS inhibitors and other antihypertensive drugs. This retrospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Hwa, Park, Jungchan, Park, Rae Woong, Shin, Seo Jeong, Kim, Jinseob, Sung, Ji Dong, Kim, Dae Jung, Yang, Kwangmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871518/
https://www.ncbi.nlm.nih.gov/pubmed/35204354
http://dx.doi.org/10.3390/diagnostics12020263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871518/
https://www.ncbi.nlm.nih.gov/pubmed/35204354
http://dx.doi.org/10.3390/diagnostics12020263

Ejemplares similares